Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Namhee Kwon

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
The European Respiratory Journal|June 26, 2021
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysisVictoria S Benson, Sylvia Hartl, Neil Barnes, et al.
Frontiers in Immunology|May 2, 2022
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic SyndromeAndreas Reiter, Guillaume Lefevre, Maria C Cid, et al.
Arthritis Care & Research|November 5, 2011
Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortalityRupert W Jakes, Sang-Cheol Bae, Worawit Louthrenoo, et al.
Journal of Patient Experience|December 19, 2022
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven DiseasesMary Jo Strobel, Debbie Alves, Florence Roufosse, et al.
Frontiers in Medicine|April 17, 2023
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndromeFlorence Roufosse, Joseph Butterfield, Jonathan Steinfeld, et al.
Clinical Rheumatology|June 23, 2021
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysisRupert W Jakes, Namhee Kwon, Beth Nordstrom, et al.
Respiratory Research|November 25, 2016
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthmaPaul M O'Byrne, Loretta Jacques, Caroline Goldfrad, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 26, 2022
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic ReviewGema Requena, Judith van den Bosch, Praveen Akuthota, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2022
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5Marc E Rothenberg, Florence Roufosse, Stanislas Faguer, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
The European Respiratory Journal|June 26, 2021
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysisVictoria S Benson, Sylvia Hartl, Neil Barnes, et al.
Frontiers in Immunology|May 2, 2022
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic SyndromeAndreas Reiter, Guillaume Lefevre, Maria C Cid, et al.
Arthritis Care & Research|November 5, 2011
Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortalityRupert W Jakes, Sang-Cheol Bae, Worawit Louthrenoo, et al.
Journal of Patient Experience|December 19, 2022
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven DiseasesMary Jo Strobel, Debbie Alves, Florence Roufosse, et al.
Frontiers in Medicine|April 17, 2023
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndromeFlorence Roufosse, Joseph Butterfield, Jonathan Steinfeld, et al.
Clinical Rheumatology|June 23, 2021
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysisRupert W Jakes, Namhee Kwon, Beth Nordstrom, et al.
Respiratory Research|November 25, 2016
Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthmaPaul M O'Byrne, Loretta Jacques, Caroline Goldfrad, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 26, 2022
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic ReviewGema Requena, Judith van den Bosch, Praveen Akuthota, et al.
Respiratory Research|August 1, 2019
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCAFrank C Albers, Alberto Papi, Camille Taillé, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2022
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5Marc E Rothenberg, Florence Roufosse, Stanislas Faguer, et al.
Pageof 5